HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Krege Selected Research

factor AF2

3/2002[Evaluation of the complementary drug Factor AF2 as a supportive agent in management of advanced urothelial carcinoma. Prospective randomized multicenter study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Krege Research Topics

Disease

16Neoplasms (Cancer)
04/2024 - 09/2000
8Residual Neoplasm
04/2014 - 12/2004
7Seminoma
04/2014 - 02/2006
6Neoplasm Metastasis (Metastasis)
11/2010 - 01/2001
6Testicular Neoplasms (Testicular Cancer)
05/2006 - 09/2000
5Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2013 - 10/2001
4Carcinoma (Carcinomatosis)
06/2018 - 03/2002
3Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 10/2003
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2018 - 01/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2009 - 11/2003
2Disease Progression
12/2009 - 10/2003
2Wounds and Injuries (Trauma)
01/2007 - 11/2003
2Prostatic Neoplasms (Prostate Cancer)
01/2006 - 10/2003
1Virilism (Virilization)
02/2014
1Urogenital Neoplasms
11/2013
1Lung Diseases (Lung Disease)
09/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2009
1Penile Neoplasms (Penile Cancer)
12/2009
1Transitional Cell Carcinoma
02/2009
1Ischemia
09/2007
1Infections
09/2007
1Spermatic Cord Torsion (Testicular Torsion)
09/2007
1Cryptorchidism (Undescended Testes)
09/2007
1Rare Diseases (Rare Disease)
07/2007
1Pain (Aches)
05/2003
1Cicatrix (Scar)
09/2001
1Erectile Dysfunction
05/2000

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
09/2012 - 01/2001
3Bleomycin (Blenoxane)FDA LinkGeneric
09/2012 - 05/2009
2pembrolizumabIBA
04/2024 - 06/2018
2Docetaxel (Taxotere)FDA Link
06/2018 - 01/2001
2Etoposide (VP 16)FDA LinkGeneric
09/2012 - 11/2010
2Carboplatin (JM8)FDA LinkGeneric
11/2010 - 02/2006
2PlatinumIBA
05/2006 - 01/2001
2Hormones (Hormone)IBA
01/2006 - 10/2003
2Methotrexate (Mexate)FDA LinkGeneric
03/2002 - 01/2001
1NivolumabIBA
04/2024
1lenvatinibIBA
04/2024
1cabozantinibIBA
04/2024
1vinflunineIBA
06/2018
1Proteins (Proteins, Gene)FDA Link
06/2018
1Paclitaxel (Taxol)FDA LinkGeneric
06/2018
1AndrogensIBA
02/2014
1Tumor Biomarkers (Tumor Markers)IBA
11/2010
1ErbB Receptors (EGF Receptor)IBA
12/2009
1Interleukin-10 (Interleukin 10)IBA
09/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2007
1Cell Adhesion MoleculesIBA
09/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2006
1GemcitabineFDA Link
01/2006
1taxaneIBA
01/2006
1Cytostatic AgentsIBA
01/2006
1Anti-Bacterial Agents (Antibiotics)IBA
11/2003
1Analgesics (Analgesic Drugs)IBA
05/2003
1factor AF2IBA
03/2002
1Immunologic Factors (Immunomodulators)IBA
03/2002
1TinIBA
10/2001
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2001
1IfosfamideFDA LinkGeneric
01/2001
1Adrenergic Receptors (Adrenergic Receptor)IBA
05/2000
1Trazodone (Trittico)FDA LinkGeneric
05/2000
1Antidepressive Agents (Antidepressants)IBA
05/2000

Therapy/Procedure

16Therapeutics
04/2024 - 09/2000
14Drug Therapy (Chemotherapy)
06/2018 - 01/2001
4Radiotherapy
04/2014 - 11/2003
4Lymph Node Excision (Lymph Node Dissection)
05/2009 - 12/2004
2Combination Drug Therapy (Combination Chemotherapy)
05/2006 - 01/2001
1Aftercare (After-Treatment)
04/2024
1Immunotherapy
06/2018
1Molecular Targeted Therapy
11/2013
1Contraindications
09/2012
1Off-Label Use
07/2007
1Myocutaneous Flap
11/2003
1Neoadjuvant Therapy
11/2003
1Sutures (Suture)
09/2001